Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988112096593
Publisher
SAGE Publications
Online
2021-01-14
DOI
10.1177/0269881120965937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glutamate and Dysconnection in the Salience Network: Neurochemical, Effective-connectivity, and Computational Evidence in Schizophrenia
- (2020) Roberto Limongi et al. BIOLOGICAL PSYCHIATRY
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
- (2020) Robert A. McCutcheon et al. World Psychiatry
- Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity
- (2020) Parita Shah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
- (2020) Andrea de Bartolomeis et al. Frontiers in Psychiatry
- Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
- (2019) Chun-Hung Chang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Targeted Treatment of Individuals with Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene
- (2019) J. Alexander Bodkin et al. BIOLOGICAL PSYCHIATRY
- Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses
- (2019) Helle B Krogh et al. BMJ Open
- The trim-and-fill method for publication bias
- (2019) Linyu Shi et al. MEDICINE
- Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)
- (2018) Dominik Strzelecki et al. PSYCHIATRY RESEARCH
- Neurophysiological Effects of Bitopertin in Schizophrenia
- (2017) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- The effects of glycine on auditory mismatch negativity in schizophrenia
- (2017) Lisa-Marie Greenwood et al. SCHIZOPHRENIA RESEARCH
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment
- (2017) Amir Krivoy et al. SCHIZOPHRENIA RESEARCH
- Targeting glutamate to treat schizophrenia: lessons from recent clinical studies
- (2016) Katherine Beck et al. PSYCHOPHARMACOLOGY
- Nature of Glutamate Alterations in Schizophrenia
- (2016) Kate Merritt et al. JAMA Psychiatry
- Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
- (2015) M. E. Goldstein et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Method Quality of Cross-Over Studies Involved in Cochrane Systematic Reviews
- (2015) Hong Ding et al. PLoS One
- Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
- (2015) Chun-Yuan Lin et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Initial Severity of Schizophrenia and Efficacy of Antipsychotics
- (2015) Toshi A. Furukawa et al. JAMA Psychiatry
- Glutamatergic agents for schizophrenia: current evidence and perspectives
- (2015) Mathias Zink et al. Expert Review of Clinical Pharmacology
- A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
- (2014) AnnCatherine M Downing et al. BMC Psychiatry
- A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study
- (2014) D. Bugarski-Kirola et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
- (2014) Hidenaga Yamamori et al. NEUROSCIENCE LETTERS
- d-Cycloserine augmentation of cognitive remediation in schizophrenia
- (2014) Christopher K. Cain et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Placebo Response in Antipsychotic Clinical Trials
- (2014) Bret R. Rutherford et al. JAMA Psychiatry
- The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
- (2013) Rebecca M. Turner et al. PLoS One
- Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences
- (2013) Jonathan Rabinowitz et al. SCHIZOPHRENIA RESEARCH
- Converting positive and negative symptom scores between PANSS and SAPS/SANS
- (2013) Theo G.M. van Erp et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
- (2012) Deepak C D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- (2011) Surendra P. Singh et al. CNS DRUGS
- Stigmatization of schizophrenia as perceived by nurses, medical doctors, medical students and patients
- (2011) G. SERAFINI et al. Journal of Psychiatric and Mental Health Nursing
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
- (2009) L Verrall et al. MOLECULAR PSYCHIATRY
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now